601 1.25mg
SSGJ-601-BRVO-III-01
Phase 3 small_molecule completed
Quick answer
601 1.25mg for Branch Retinal Vein Occlusion is a Phase 3 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Branch Retinal Vein Occlusion
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed